FAQs

E-cigarettes ('vapes') contain chemicals such as nicotine, propylene glycol, glycerine, and flavourings.

E-cigarettes also contain many chemicals considered to be hazardous. These include formaldehyde, acetaldehyde and acrolein, which are known causes of cancer. Some chemicals in e-cigarette aerosols can cause DNA damage.

The long-term effects of vaping are unknown, therefore the safety of vaping cannot be guaranteed.

Learn more

Talk to them about e-cigarettes early on… Just as you might talk to young people about alcohol and other drugs, or keeping safe on the internet, it’s a good idea to include e-cigarettes as part of that conversation. Ask your child to research e-cigarettes together as you both may not know a lot about e-cigarettes. There’s lots of useful information on this site and links to other resources.

If you are worried that your child is vaping, your first impulse may be to tell them all the risks or to punish them. Instead take a deep breath and plan how to communicate. Be curious – “What do you think about vaping?”. If they tell you they have tried it, thank them for telling you and ask about their experience – “How did you find it?”

Aim to keep the conversations positive and try not to judge or lecture them.

Share how you feel in a simple open way about the behaviour – “When you vape, I worry about your health. I would like to help you work out what you want to do about vaping.”

If they say they have not tried it, share how you feel in a simple open way. “I know some kids are trying vaping. If you do try it, I would want to know so we can talk about it.” Look out for changes in behaviour for signs of nicotine dependence.

If you’re noticing changes in the young person’s behaviour within a 30-60min window (as they may not been able to vape during this time) it is highly likely they are experiencing nicotine withdrawals.

Learn more

The labels on most vapes don't necessarily accurately describe what’s in them. Several studies have found that over 80% of e-cigarette labels that say they don’t contain nicotine do, in fact, contain nicotine. It is reasonable to assume that anyone finding themselves addicted to vaping is inhaling nicotine.

People can access one-on-one private telephone counselling through Quitline. Quitline counsellors can talk with them about their experiences and offer guidance and support.

There are many ways to contact Quitline:

• Call 13 7848 Mon - Fri 8am to 8pm
• Text 'call back' to 0482 090 634
• Webchat at quit.org.au
• Message us on Facebook Messenger @quitvic or WhatsApp: +61 385 832 920
• Request a call back using the online form at quit.org.au

Your GP can also provide invaluable support tailored to the individual. It’s worth also visiting the Resources page on this website to read up about information on e-cigarettes.

Quitline can talk with you about your concerns, provide advice on what you can do as a parent or carer, and guide you on how you can start a conversation with your teen.

There are many ways to contact Quitline:

• Call 13 7848 Mon - Fri 8am to 8pm
• Text 'call back' to 0482 090 634
• Webchat at quit.org.au
• Message us on Facebook Messenger @quitvic or WhatsApp: +61 385 832 920
• Request a call back using the online form at quit.org.au

You can also visit our ‘Start the conversation’ section of this site for more information.

Continue with calm conversations using open communication techniques and asking curious questions. Try to understand that it may be difficult for the young person addicted to vaping talk about their dependency on nicotine. It may help to regularly suggest they speak with Quitline counsellors who understand the challenges with stopping vaping. You could also chat to your GP or consult other Resources on this website.

See the new resource ‘Seeing Through the Haze’, designed for use in schools to build health literacies, prevent vaping uptake and maintain low smoking prevalence among young people.

Yes, some of the largest tobacco companies have been investing in and developing e-cigarette products for many years. Vaping has been described by many as the resurgence of the tobacco industry.

The dependency on e-cigarettes (especially nicotine) can be very powerful. Not having an e-cigarette can be stressful and can lead to anxiety. Nicotine can amplify stress and anxiety as well as increase symptoms of depression. Support is available through Quitline to stop. Call 13 7848 or visit quit.org.au

It took many decades of evidence-based research to understand the full extent of the health harms of smoking cigarettes. Research into vaping and e-cigarettes is still emerging. We do know that over 200 chemicals have been found in e-cigarette liquids. Many of these are hazardous, including those found in weed killer, bug spray and even paint thinner.

A person who vapes regularly may inhale these chemicals into their lungs many times a day, every day, for many years. The long-term effects of exposure to these chemicals in this way are not yet known. The only thing your lungs should be breathing in is fresh air.

Vaping can cause seizures, lung injury and facial damage (from exploding vapes). The nicotine in vapes may impair brain development in young people. It’s possible that vaping may worsen mood disorders, reduce concentration and interrupt sleep in those addicted. The long-term effects of vaping won’t be known for many years.

1. National Health and Medical Research Council. Inhalation toxicity of non-nicotine e-cigarette constituents: risk assessments, scoping review and evidence map. 2022. View PDF
2. NHMRC CEO statement Visit Site
3. Therapeutic Goods Administration. Testing of nicotine vaping products. Australian Government, Department of Health, 2022. Visit Site
4. U.S. Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. View PDF
5. England LJ, Bunnell RE, Pechacek TF, Tong VT, and McAfee TA. Nicotine and the developing human: a neglected element in the electronic cigarette debate. American Journal of Preventive Medicine, 2015; 49(2):286–93. Visit Site
6. Banks E, Yazidjoglou A, Brown S, Nguyen M, Martin M, et al. Electronic cigarettes and health outcomes: systematic review of global evidence. Report for the Australian Department of Health. Canberra: National Centre for Epidemiology and Population Health, 2022. Visit Site
7. Wang X, Lee NL, and Burstyn I. Smoking and use of electronic cigarettes (vaping) in relation to preterm birth and small-for-gestational-age in a 2016 U.S. national sample. Preventive Medicine, 2020; 134:106041. Visit Site
8. Cardenas VM, Cen R, Clemens MM, Moody HL, Ekanem US, et al. Use of electronic nicotine delivery systems (ENDS) by pregnant women I: risk of small-for-gestational-age birth. Tobacco Induced Diseases, 2019; 17:44. Visit Site
9. Kim S and Oancea SC. Electronic cigarettes may not be a "safer alternative" of conventional cigarettes during pregnancy: evidence from the nationally representative PRAMS data. BMC Pregnancy Childbirth, 2020; 20(1):557. Visit Site
10. Regan AK, Bombard JM, O'Hegarty MM, Smith RA, and Tong VT. Adverse birth outcomes associated with prepregnancy and prenatal electronic cigarette use. Obstetrics & Gynecology, 2021; 138(1):85-94. Visit Site
11. Baenziger, O. N., Ford, L., Yazidjoglou, A., Joshy, G., & Banks, E. E-cigarette use and combustible tobacco cigarette smoking uptake among non-smokers, including relapse in former smokers: umbrella review, systematic review and meta-analysis. BMJ open, 2021; 11(3), e045603. Visit Site
12. Chivers E, Janka M, Franklin P, Mullins B, and Larcombe A. Nicotine and other potentially harmful compounds in "nicotine-free" e-cigarette liquids in Australia. Medical Journal of Australia, 2019; 210(3):127–8. Visit Site
13. Larcombe A, Allard S, Pringle P, Mead-Hunter R, Anderson N, et al. Chemical analysis of fresh and aged Australian e-cigarette liquids. Medical Journal of Australia, 2022; 216(1):27-32. Visit Site
14. National Industrial Chemicals Notification and Assessment Scheme (NICNAS). Non-nicotine liquids for e-cigarette devices in Australia: chemistry and health concern. Australian Government Department of Health, 2019. View PDF
15. Winnall, WR, Greenhalgh, EM, Bayly, M and Scollo, MM. 18.5 Chemicals in e-liquids and e-cigarette aerosols. In Greenhalgh EM, Scollo, MM and Winstanley, MH [editors]. Tobacco in Australia: Facts and issues. Melbourne: Cancer Council Victoria; 2023. Visit Site
16. Ingebrethsen BJ, Cole SK, and Alderman SL. Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol, 2012; 24(14):976-84. Visit Site
17. Mikheev VB, Brinkman MC, Granville CA, Gordon SM, and Clark PI. Real-time measurement of electronic cigarette aerosol size distribution and metals content analysis. Nicotine & Tobacco Research, 2016; 18(9):1895-902. Visit Site
18. Manigrasso M, Buonanno G, Fuoco FC, Stabile L, and Avino P. Aerosol deposition doses in the human respiratory tree of electronic cigarette smokers. Environmental Pollution, 2015; 196:257-67. Visit Site
19. Lechasseur, A., Altmejd, S., Turgeon, N., Buonanno, G., Morawska, L., Brunet, D., Duchaine, C., & Morissette, M. C. Variations in coil temperature/power and e-liquid constituents change size and lung deposition of particles emitted by an electronic cigarette. Physiological reports, 2019; 7(10), e14093. Visit Site
20. Ooi, B. G., Dutta, D., Kazipeta, K., & Chong, N. S. Influence of the e-cigarette emission profile by the ratio of glycerol to propylene glycol in e-liquid composition. ACS omega, 2019; 4(8), 13338–13348. Visit Site
21. Hiler, M., Weidner, A. S., Hull, L. C., Kurti, A. N., & Mishina, E. V. Systemic biomarkers of exposure associated with ENDS use: a scoping review. Tobacco control, 2023; 32(4), 480–488. Visit Site
22. Benowitz, N. L., Hukkanen, J., & Jacob, P., 3^rd. Nicotine Chemistry, Metabolism, Kinetics and Biomarkers. Handbook of experimental pharmacology, 2009; (192), 29–60. Visit Site
23. Watts, C., Egger, S., Dessaix, A., Brooks, A., Jenkinson, E., Grogan, P., & Freeman, B. Vaping product access and use among 14-17-year-olds in New South Wales: a cross-sectional study. Australian and New Zealand Journal of Public Health, 2022; 46(6), 814–820. Visit Site
24. Benowitz NL. Nicotine addiction. New England Journal of Medicine, 2010; 362(24):2295–303. Visit Site
25. McNeill AD. The development of dependence on smoking in children. British Journal of Addiction, 1991; 86(5):589–92. Visit Site
26. O'Loughlin J, DiFranza J, Tyndale RF, Meshefedjian G, McMillan-Davey E, et al. Nicotine-dependence symptoms are associated with smoking frequency in adolescents. American Journal of Preventive Medicine, 2003; 25(3):219–25. Visit Site
27. Doubeni CA, Reed G, and Difranza JR. Early course of nicotine dependence in adolescent smokers. Pediatrics, 2010; 125(6):1127–33. Visit Site
28. Scully M, Bain E, Koh I, Wakefield M, Durkin S. (2023). ASSAD 2022/2023: Australian secondary school student's use of tobacco and e-cigarettes. Prepared for Australian Government Department of Health and Aged Care by Centre for Behavioural Research in Cancer, Cancer Council Victoria. Australian secondary school students’ use of tobacco and e-cigarettes (health.gov.au)